Oramorph sr and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Oramorph sr (morphine sulfate), especially for people who are male, 60+ old, also take Lansoprazole, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have Weakness when taking Oramorph sr. It is created by eHealthMe based on reports of 2,797 people who have side effects when taking Oramorph sr from the FDA, and is updated regularly.

What is Oramorph sr?

Oramorph sr has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 2,897 Oramorph sr users. Check the latest studies of Oramorph sr.

What is Weakness?

Weakness is found to be associated with 3,638 drugs and 6,618 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

2,797 people reported to have side effects when taking Oramorph sr.
Among them, 78 people (2.79%) have Weakness.

Among these 78 people:

What is the gender of people who have Weakness when taking Oramorph sr? *

female: 50 %
male: 50 %

What is the age of people who have Weakness when taking Oramorph sr? *

What are other drugs people take besides Oramorph sr? *

What are other side effects people have besides Weakness? *

Diarrhea: 28 people, 35.90%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 26 people, 33.33%
Dehydration (dryness resulting from the removal of water): 23 people, 29.49%
Nausea (feeling of having an urge to vomit): 23 people, 29.49%
Nausea And Vomiting: 23 people, 29.49%
Constipation: 23 people, 29.49%
Dyspnea (difficult or laboured breathing): 22 people, 28.21%
Swallowing Difficulty: 21 people, 26.92%
Fatigue (feeling of tiredness): 19 people, 24.36%
Headache (pain in head): 17 people, 21.79%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 21 people, 26.92%
Nausea And Vomiting: 14 people, 17.95%
High Blood Pressure: 14 people, 17.95%
Swallowing Difficulty: 13 people, 16.67%
Neutropenic Sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection): 13 people, 16.67%
Depression: 12 people, 15.38%
Transitional Cell Carcinoma (cancer tumour inner most layer of urinary system): 12 people, 15.38%
Lung Cancer - Small Cell (lung cancer): 12 people, 15.38%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 12 people, 15.38%
Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 7 people, 8.97%

* Approximation only. Some reports may have incomplete information.

Do you take Oramorph sr and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Oramorph sr:

Oramorph sr (2,897 reports)

Weakness treatments and more:

Weakness (586,877 reports)

Browse all side effects of Oramorph sr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,638 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,618 conditions)

Related publications that referenced our studies

Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate (the active ingredients of Oramorph sr) and Oramorph sr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.